• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACR 适宜性标准:乳腺癌筛查。

ACR Appropriateness Criteria Breast Cancer Screening.

机构信息

Rhode Island Hospital, Providence, RI, USA.

出版信息

J Am Coll Radiol. 2013 Jan;10(1):11-4. doi: 10.1016/j.jacr.2012.09.036.

DOI:10.1016/j.jacr.2012.09.036
PMID:23290667
Abstract

Mammography is the recommended method for breast cancer screening of women in the general population. However, mammography alone does not perform as well as mammography plus supplemental screening in high-risk women. Therefore, supplemental screening with MRI or ultrasound is recommended in selected high-risk populations. Screening breast MRI is recommended in women at high risk for breast cancer on the basis of family history or genetic predisposition. Ultrasound is an option for those high-risk women who cannot undergo MRI. Recent literature also supports the use of breast MRI in some women of intermediate risk, and ultrasound may be an option for intermediate-risk women with dense breasts. There is insufficient evidence to support the use of other imaging modalities, such as thermography, breast-specific gamma imaging, positron emission mammography, and optical imaging, for breast cancer screening. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

摘要

乳腺 X 线摄影是一般人群中女性乳腺癌筛查的推荐方法。然而,乳腺 X 线摄影本身在高危女性中的表现不如乳腺 X 线摄影加补充筛查。因此,建议在选定的高危人群中进行 MRI 或超声补充筛查。

基于家族史或遗传易感性,推荐对乳腺癌高危女性进行乳腺 MRI 筛查。对于不能进行 MRI 的高危女性,可以选择超声检查。最近的文献也支持在一些中等风险女性中使用乳腺 MRI,而对于乳腺密度较高的中等风险女性,超声可能是一种选择。

没有足够的证据支持使用其他成像方式,如热成像、乳腺特异性伽马成像、正电子发射乳腺摄影和光学成像,进行乳腺癌筛查。ACR 适宜性标准是针对特定临床情况的基于证据的指南,由多学科专家小组每两年审查一次。指南的制定和审查包括对同行评议期刊上的当前医学文献进行广泛分析,并应用成熟的共识方法(改良 Delphi)对小组对成像和治疗程序的适宜性进行评分。在缺乏证据或证据不明确的情况下,可以使用专家意见来推荐成像或治疗。

相似文献

1
ACR Appropriateness Criteria Breast Cancer Screening.ACR 适宜性标准:乳腺癌筛查。
J Am Coll Radiol. 2013 Jan;10(1):11-4. doi: 10.1016/j.jacr.2012.09.036.
2
ACR Appropriateness Criteria Breast Cancer Screening.美国放射学会适宜性标准:乳腺癌筛查
J Am Coll Radiol. 2016 Nov;13(11S):R45-R49. doi: 10.1016/j.jacr.2016.09.021.
3
The use of breast imaging to screen women at high risk for cancer.利用乳腺成像技术对癌症高危女性进行筛查。
Radiol Clin North Am. 2010 Sep;48(5):859-78. doi: 10.1016/j.rcl.2010.06.012.
4
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.该使用哪种风险模型?ACS MRI 筛查指南的临床意义。
Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):146-9. doi: 10.1158/1055-9965.EPI-12-0570. Epub 2012 Oct 23.
5
ACR Appropriateness Criteria® stage I breast carcinoma.ACR 适宜性标准®Ⅰ期乳腺癌。
J Am Coll Radiol. 2012 Jul;9(7):463-7. doi: 10.1016/j.jacr.2012.03.011.
6
ACR Appropriateness Criteria stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women.ACR 适宜性标准Ⅰ期乳腺癌:无症状女性局部复发和远处转移的初始检查和监测。
J Am Coll Radiol. 2014 Dec;11(12 Pt A):1160-8. doi: 10.1016/j.jacr.2014.08.020. Epub 2014 Oct 23.
7
ACR Appropriateness Criteria Palpable Breast Masses.美国放射学会(ACR)乳腺可触及肿块的适宜性标准
J Am Coll Radiol. 2016 Nov;13(11S):e31-e42. doi: 10.1016/j.jacr.2016.09.022.
8
ACR Appropriateness Criteria® on nonpalpable mammographic findings (excluding calcifications).ACR 适宜性标准® 用于非扪及性乳腺 X 线摄影所见(不包括钙化)。
J Am Coll Radiol. 2010 Dec;7(12):920-30. doi: 10.1016/j.jacr.2010.07.006.
9
ACR Appropriateness Criteria Stage I Breast Carcinoma.美国放射学会(ACR)适宜性标准:Ⅰ期乳腺癌
J Am Coll Radiol. 2016 Nov;13(11S):e53-e57. doi: 10.1016/j.jacr.2016.09.024.
10
ACR Appropriateness Criteria Breast Cancer Screening.美国放射学会(ACR)乳腺癌筛查适宜性标准
J Am Coll Radiol. 2017 Nov;14(11S):S383-S390. doi: 10.1016/j.jacr.2017.08.044.

引用本文的文献

1
Association Between Microcalcification Patterns in Mammography and Breast Tumors in Comparison to Histopathological Examinations.乳腺钼靶摄影中微钙化模式与乳腺肿瘤的关联:与组织病理学检查的比较
Diagnostics (Basel). 2025 Jul 2;15(13):1687. doi: 10.3390/diagnostics15131687.
2
Clinical guidelines for the management of mammographic density: a systematic review of breast screening guidelines worldwide.乳腺X线密度管理临床指南:全球乳腺筛查指南的系统评价
JNCI Cancer Spectr. 2024 Nov 1;8(6). doi: 10.1093/jncics/pkae103.
3
Breast Imaging Physics in Mammography (Part I).
乳腺钼靶摄影中的乳腺成像物理学(第一部分)。
Diagnostics (Basel). 2023 Oct 17;13(20):3227. doi: 10.3390/diagnostics13203227.
4
Triple assessment breast clinics: The value of clinical core biopsies.三阴性乳腺癌临床诊疗中心:临床核心活检的价值。
Ir J Med Sci. 2024 Apr;193(2):565-570. doi: 10.1007/s11845-023-03445-z. Epub 2023 Aug 8.
5
Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?对于辅助生殖治疗的候选者,超声检测出的BIRADS-3级乳腺肿块,磁共振成像(MRI)是否具有附加价值?
Eur J Radiol Open. 2022 Dec 30;10:100474. doi: 10.1016/j.ejro.2022.100474. eCollection 2023.
6
Young Black Women May be More Likely to Have First Mammogram Cancers: A New Perspective in Breast Cancer Disparities.年轻黑人女性首次乳腺钼靶检查发现癌症的可能性可能更高:乳腺癌差异研究的新视角。
Ann Surg Oncol. 2023 May;30(5):2856-2869. doi: 10.1245/s10434-022-12995-y. Epub 2023 Jan 5.
7
Breast Cancer Incidence in Kyrgyzstan: Report of 15 Years of Cancer Registry.吉尔吉斯斯坦乳腺癌发病率:15 年癌症登记报告。
Asian Pac J Cancer Prev. 2022 May 1;23(5):1603-1610. doi: 10.31557/APJCP.2022.23.5.1603.
8
Detection of breast cancer by ATR-FTIR spectroscopy using artificial neural networks.基于人工神经网络的 ATR-FTIR 光谱法检测乳腺癌。
PLoS One. 2022 Jan 26;17(1):e0262489. doi: 10.1371/journal.pone.0262489. eCollection 2022.
9
Surgical Management of Hereditary Breast Cancer.遗传性乳腺癌的外科治疗。
Genes (Basel). 2021 Aug 31;12(9):1371. doi: 10.3390/genes12091371.
10
Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis.使用乳腺 MRI 对有乳腺癌个人史的女性进行第二乳腺癌事件监测的系统评价和荟萃分析。
Breast Cancer Res Treat. 2020 Jun;181(2):255-268. doi: 10.1007/s10549-020-05637-y. Epub 2020 Apr 17.